HIGHLIGHTS
- who: Martin Magner and colleagues from the Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University have published the Article: Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study, in the Journal: Nutrients 2023, 15, 718. of /2023/
- what: As young children with diagnosed autism are believed to be sensitive to any possible therapeutic intervention, the authors aimed to examine the possible effect of SFN in the age cohort of three to seven years in this study by using the objective and subjective criteria for mental and behavioural . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.